91社区

Please note: The Research + Innovation office will be closed for the holidays from noon on December 24 through January 2nd, inclusive. 鉂勶笍 Veuillez noter que le bureau de la Recherche et de l'Innovation sera ferm茅 pour les vacances du 24听d茅cembre 脿 midi jusqu鈥檃u 2听janvier inclus.

News

At-home neurological disorder diagnosis project receives major funding

Published: 8 November 2024

$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson鈥檚 disease

REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What鈥檚 worse, people with the disorder often go on to develop Parkinson鈥檚 disease.

RBD can be difficult to diagnose because the behaviour happens while the person is unaware. A new project aiming to provide at-home diagnosis using wearable technology has been awarded a $1M grant by The Weston Family Foundation.

Led by Dr. Ron Postuma, a clinician-researcher at The Neuro of 91社区 and Director of the Division of Neurology at the 91社区 Health Centre, the project will develop a quick and accurate diagnostic tool for RBD by using actigraphy and state-of-the-art data analysis. Actigraphy is the monitoring and recording of motor activity while awake and asleep. The goal of the project is to pave the way for an inexpensive and easy to use method of identifying RBD patients, and potentially predicting their likelihood of developing Parkinson鈥檚 later in life.

About the grant

The Weston Family Foundation鈥檚 Brain Health: Sleep 2023 program follows growing evidence that making key lifestyle changes may reduce the risk of brain diseases of aging and slow cognitive decline. The program aims to reduce the risk and/or slow the progression of neurodegenerative diseases of aging by accelerating the development of healthy lifestyle approaches relating to sleep.

In all, are being awarded for their work around their development of sleep-based strategies to improve brain-related outcome measures relevant to, or associated with, neurodegenerative diseases of aging.

Back to top